Why Is Linzess So Hard to Find? [Explained for 2026]

If you've been prescribed Linzess (linaclotide) and found yourself calling pharmacy after pharmacy without success, you're not alone. Despite not being on any official FDA shortage list, Linzess is a medication that many patients report difficulty filling at their local pharmacy. In this article, we break down exactly why that happens—and what you can do about it.

Is Linzess Actually in a Shortage?

As of 2026, Linzess (linaclotide) is not listed on the FDA Drug Shortages Database or the ASHP shortage list. This means there is no official, nationwide supply disruption affecting Linzess. The drug is manufactured by AbbVie in partnership with Ironwood Pharmaceuticals and has been available since its FDA approval in 2012.

However, "not in an official shortage" doesn't mean "easy to find." Many patients still run into barriers filling their Linzess prescription—and the reasons are worth understanding.

Why Do Patients Struggle to Find Linzess?

There are several distinct reasons why Linzess can be hard to fill, and they vary by patient. Here are the most common:

1. Linzess Is Brand-Name Only (No Generic Available)

One of the biggest reasons Linzess is hard to access comes down to cost and formulary placement. As of 2026, no generic version of linaclotide is available in the United States. Teva Pharmaceuticals has an agreement to launch a generic 72 mcg version beginning March 31, 2029—with 145 mcg and 290 mcg generics expected by early 2030. Until then, patients are stuck paying brand-name prices.

The wholesale acquisition cost (WAC) for Linzess is $282.48 per month as of January 2026, and retail cash prices at pharmacies range from $680 to over $736 for a 30-day supply. Without insurance or a savings program, this puts Linzess out of reach for many patients.

2. Prior Authorization and Step Therapy Requirements

Even if your insurance covers Linzess, you may hit a roadblock called prior authorization (PA) or step therapy. Many commercial insurance plans and Medicare Part D plans place Linzess on Tier 2 or Tier 3 of their formulary. This often means:

• Your doctor must submit documentation proving Linzess is medically necessary
• You may be required to try and fail a cheaper drug first (step therapy), such as an OTC laxative or generic lubiprostone (Amitiza)
• Approval can take days or weeks, leaving you without medication in the meantime

According to AbbVie and Ironwood, approximately 98% of commercial health insurance plans cover Linzess—but coverage doesn't guarantee immediate access if a PA is pending.

3. Not All Pharmacies Stock Linzess

Because Linzess is a brand-name-only drug with a relatively high cost, some smaller or independent pharmacies may not keep it in stock regularly. Pharmacies order based on demand, and low turnover drugs may not be restocked immediately. This is especially common in rural areas or at pharmacies that don't specialize in GI medications.

Larger chain pharmacies (CVS, Walgreens, Rite Aid, Walmart, Costco) and mail-order pharmacies typically carry Linzess more reliably than smaller independents.

4. Insurance Gaps: Medicare and Medicaid Hurdles

Medicare Part D plans typically list Linzess on Tier 3, which carries higher cost-sharing. While the $2,100 Medicare Part D out-of-pocket cap (effective 2026) helps reduce catastrophic drug costs, patients can still pay significant amounts before reaching that threshold.

Medicaid coverage for Linzess varies by state. Some state Medicaid programs cover it, especially after step therapy failures, while others require the prescribing physician to obtain a prior authorization each year.

What Can You Do When You Can't Find Linzess?

Here are your best options if you're struggling to fill your Linzess prescription:

1. Use medfinder: medfinder.com calls pharmacies near you to find which ones have Linzess in stock, saving you hours of calling around yourself.
2. Use the Linzess Savings Program: With commercial insurance, you may pay as little as $30 per month (max $2,280 in savings per calendar year). Call 1-855-859-5614 or text LINZESS to 59257.
3. Apply for the AbbVie Patient Assistance Foundation: Uninsured patients with limited income may receive up to 12 months of Linzess at no cost. Call 1-800-222-6885 or visit abbviepaf.org.
4. Try a discount card: GoodRx and SingleCare can bring your out-of-pocket cost from $736 down to approximately $252 per month at participating pharmacies.
5. Ask about alternatives: Drugs like Trulance (plecanatide), Amitiza (lubiprostone), or Motegrity (prucalopride) treat the same conditions. Read more in our guide to Linzess alternatives.

The Bottom Line

Linzess is not in a national shortage, but its brand-only status, high cost, insurance hurdles, and inconsistent pharmacy stocking mean many patients face real barriers filling their prescription. The good news: with the right savings programs and tools, most patients can get access. Read our full guide on how to find Linzess in stock near you for step-by-step help.